Liver and gall F1: Liver or gallbladder problems with high blood pressure, red, swollen eyes, severe headache, bitter and sticky mouth or discomfort in the rib cage area.
1. Liver and gallbladder: Hepatitis jaundice: Two reports on 62 patients taking the F1 formula for a month found 57 were cured (91.93%), 4 significantly improved (6.45%) and one did not improve. Another report on 172 acute jaundice patients taking F1 or its modifications showed all cured in 30 to 40 days. Acute gallbladder infections: In two reports, 9 patients with acute gallbladder infections taking F1 and its modifications were all cured in 8 to11 days.
2. High blood pressure: Three clinical reports on 48 HBP patients taking F1 found only four did not improve after treatment. The total cure and effectiveness rate exceeded 91.67 percent.
3. Improved immune system: F1 can help to increase the immune system. In lab mice, at 50g/Kg dosage, the engulfing rate of macropharge cells was tested in 3 hours and 6 hours later. These results were compared with the comparison group. Engulfing rate at 3 hours is: 17.77 vs. 5.96; at 6 hours: 44 vs. 15.86. There is a very significant difference, p<0.05. The F1 formula also increased the transforming rate of lymph cells-- 14% at 0.05ml and 36% at 0.15ml dosage. Plateau red-cell syndromes: Of 35 patients using F1 to treat plateau red-cell syndromes, 24 were cured (68.6%), 8 improved (22.8%) and 3 did not (8.6%). Another report on 130 patients who were divided into a treatment group (n=70) using F1 and western medicine together and a comparison group (n=60) using western medicine only found: Cured: 58 vs. 35 (82.9% vs. 50%), improved: 10 vs. 15 (14.3% vs. 25%), did not improve: 2 vs. 10 (2.8% vs. 16.67%). There are very significant differences between two groups, p<0.01. Urinary tract infection: Of 14 acute or chronic urinary tract infection patients taking F1 from 3 to 13 days, 12 were cured (85.71%) and 2 improved (14.29%). Of 52 acute Pyelonephritis patients taking F1, 48 cured (92.39%), 4 improved (7.61%). Urine test turned negative in an average of 7 days.
5. Leukemia: Of 26 bone-marrow autopsy-confirmed acute leukemia patients taking F1 or its modifications along with western medicine, 14 reached total remission (53.84%), 10 reached partial remission (38.46%) and 2 did not improve.
6. Hyperthyroid: Two reports on 19 patients with high T3, T4 and I131 taking F1 formula showed 7 cured (36.84%), 11 improved (57.89%) and only one did not improve.
7. Diabetes: Of 36 overweight patients with high cholesterol problems, from 50 to 69 years old and with empty stomach glucose all >5.6mmol/L, 28 were cured (77.77%), 5 (13.88%) significantly improved and 3 improved after F1 treatment.
8. Acute upper digestive tract bleeding: 200 patients were divided into a treat- ment group (n=100) using F1 or its modification and a comparison group (n=100) using Cimetidinum. The total effectiveness rate was 98% versus 80%. Stool-blood test showed to negative in 4 days among the treatment group, while the comparison group required 6.2 days, p<0.05.
9. Acne and pimples: Of 50 patients taking F1 or its modification, 10 were cured (20%), 21 significantly improved (42%), 10 improved (20%) and 9 did not (18%).
10. Herpes: Of 336 patients using F1 from 7 to 14 days, 318 were cured (94.64%) and 18 significantly improved (5.36%). A report on 100 patients who were divided into a treatment group (n=58) and a comparison group (n=42) using Vit. B 100 mg IV injections and Vit. B.12 at 200ug showed: Cured: 56 vs. 30 (96.55% vs. 71.42%), improved: 2 vs. 5 (3.45% vs. 11.90%) and 7 cases in comparison group did not improve ( 0% vs. 16.67%). There is a significant difference between two groups.
11. Rashes: Four reports on 50 rash patients taking F1 for up to two weeks found 42 were cured (84%) and 8 improved (16%).
12. Male sexual problems: Ejaculation difficulty: In two reports on 16 patients were all cured in 45 days. Acute orchitis: Two reports on 48 patients showed all but two cured after treatment. Prostatitis: Two reports on 74 patients taking F1 or its modifications found 34 were cured (45.94%), 20 significantly improved (41.66%), 15 improved (20.27%) and 5 did not (6,76%).
13. Female problems: Acute pelvic inflammation: 7 patients were all cured in 10 days. Uterus prolapse: Of 25 females in two reports taking F1, 12 were cured (48%), 12 improved (48%) and one did not improve after treatment. Cervical infection: Of 356 chronic cervical infection patients taking F1, 332 patients (93.3%) were either cured or improved.
Toxicity and side effects: In animal tests, LD50 of F1 is 72g/kg. Some patients may experience mild diarrhea or loose stool in the first couple of days of taking the F6 formula.
